Adam Koppel
Affiliations
- at Cerevel Therapeutics Holdings Inc. (CERE), 2024-08-05
- at Foghorn Therapeutics Inc. (FHTX), 2024-06-28
- at Solid Biosciences Inc. (SLDB), 2024-01-12
- Large Shareholder, Director at Aptinyx Inc. (APTX), 2022-05-31
- Director at Dicerna Pharmaceuticals Inc (DRNA), 2021-12-29
- Large Shareholder at Springworks Therapeutics Inc. (SWTX), 2021-08-13
- Large Shareholder at Rapid Micro Biosystems Inc. (RPID), 2021-07-21
- Large Shareholder, Director at Bcls Acquisition Corp. (BLSA), 2020-10-26
- Large Shareholder at Annexon Inc. (ANNX), 2020-07-28
- Large Shareholder at Arcutis Biotherapeutics Inc. (ARQT), 2020-02-06
- Director at Replimune Group Inc. (REPL), 2018-07-26
- Director at Trevena Inc (TRVN), 2018-05-17
- Large Shareholder at Marinus Pharmaceuticals Inc (MRNS), 2017-12-20
- Director at Ptc Therapeutics Inc. (PTCT), 2017-01-06
- Evp, Strategy And Bus. Dev. at Biogen Inc. (BIIB), 2016-06-07
Insider Trading: Purchases See All
| Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|---|
| CERE | $22.81 | 5,480,052 | Large Shareholder, Director | 65,679,781 | 2023-10-16 | Filing | |
| CERE | $10.30 | 332,293 | Large Shareholder, Director | 60,632,356 | 2020-11-09 | Filing | |
| CERE | $10.00 | 10,000,000 | Large Shareholder, Director | 60,300,063 | 2020-10-27 | Filing | |
| APTX | $3.00 | 3,333,333 | Large Shareholder, Director | 5,558,425 | 2020-01-14 | Filing | |
| APTX | $16.00 | 400,000 | Director | 2,225,092 | 2018-06-25 | Filing |
Insider Trading: Sales See All